Kunitz-type soybean trypsin inhibitor revisited

Refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator

Hyun Kyu Song, Se Won Suh

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

The Kunitz-type trypsin inhibitor from soybean (STI) consists of 181 amino acid residues with two disulfide bridges. Its crystal structures have been determined in complex with porcine pancreatic trypsin in two crystal forms (an orthorhombic form at 1.75 Å resolution and a tetragonal form at 1.9 Å) and in the free state at 2.3 Å resolution. They have been refined to crystallographic X-values of 18.9%, 21.6% and 19.8%, respectively. The three models of STI reported here represent a significant improvement over the partial inhibitor structure in the complex, which was previously determined at a nominal resolution of 2.6 Å by the multiple isomorphous replacement method. This study provides the first high-resolution picture of the complex between a Kunitz-type proteinase inhibitor with its cognate proteinase. Many of the external loops of STI show high B-factors, both in the free and the complexed states, except the reactive site loop whose B-factors are dramatically reduced upon complexation. The reactive site loop of STI adopts a canonical conformation similar to those in other substrate-like inhibitors. The P1 carbonyl group displays no out-of-plane displacement and thus retains a nominal trigonal planar geometry. Modeling studies on the complex between a homologous Kunitz-type trypsin inhibitor DE-3 from Erythrina caffra and the human tissue-type plasminogen activator reveal a new insight into the specific interactions which could play a crucial role in their binding.

Original languageEnglish
Pages (from-to)347-363
Number of pages17
JournalJournal of Molecular Biology
Volume275
Issue number2
DOIs
Publication statusPublished - 1998 Jan 16
Externally publishedYes

Fingerprint

Kunitz Soybean Trypsin Inhibitor
Erythrina
Tissue Plasminogen Activator
Sexually Transmitted Diseases
Trypsin
Swine
Catalytic Domain
Peptide Hydrolases
Disulfides
Amino Acids

Keywords

  • β-trefoil fold
  • Crystal structure
  • Inhibition of plasminogen activator
  • Kunitz-type proteinase inhibitor
  • Soybean trypsin inhibitor

ASJC Scopus subject areas

  • Virology

Cite this

@article{a74fe0e45d3940698a0f470eec1df138,
title = "Kunitz-type soybean trypsin inhibitor revisited: Refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator",
abstract = "The Kunitz-type trypsin inhibitor from soybean (STI) consists of 181 amino acid residues with two disulfide bridges. Its crystal structures have been determined in complex with porcine pancreatic trypsin in two crystal forms (an orthorhombic form at 1.75 {\AA} resolution and a tetragonal form at 1.9 {\AA}) and in the free state at 2.3 {\AA} resolution. They have been refined to crystallographic X-values of 18.9{\%}, 21.6{\%} and 19.8{\%}, respectively. The three models of STI reported here represent a significant improvement over the partial inhibitor structure in the complex, which was previously determined at a nominal resolution of 2.6 {\AA} by the multiple isomorphous replacement method. This study provides the first high-resolution picture of the complex between a Kunitz-type proteinase inhibitor with its cognate proteinase. Many of the external loops of STI show high B-factors, both in the free and the complexed states, except the reactive site loop whose B-factors are dramatically reduced upon complexation. The reactive site loop of STI adopts a canonical conformation similar to those in other substrate-like inhibitors. The P1 carbonyl group displays no out-of-plane displacement and thus retains a nominal trigonal planar geometry. Modeling studies on the complex between a homologous Kunitz-type trypsin inhibitor DE-3 from Erythrina caffra and the human tissue-type plasminogen activator reveal a new insight into the specific interactions which could play a crucial role in their binding.",
keywords = "β-trefoil fold, Crystal structure, Inhibition of plasminogen activator, Kunitz-type proteinase inhibitor, Soybean trypsin inhibitor",
author = "Song, {Hyun Kyu} and Suh, {Se Won}",
year = "1998",
month = "1",
day = "16",
doi = "10.1006/jmbi.1997.1469",
language = "English",
volume = "275",
pages = "347--363",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Kunitz-type soybean trypsin inhibitor revisited

T2 - Refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator

AU - Song, Hyun Kyu

AU - Suh, Se Won

PY - 1998/1/16

Y1 - 1998/1/16

N2 - The Kunitz-type trypsin inhibitor from soybean (STI) consists of 181 amino acid residues with two disulfide bridges. Its crystal structures have been determined in complex with porcine pancreatic trypsin in two crystal forms (an orthorhombic form at 1.75 Å resolution and a tetragonal form at 1.9 Å) and in the free state at 2.3 Å resolution. They have been refined to crystallographic X-values of 18.9%, 21.6% and 19.8%, respectively. The three models of STI reported here represent a significant improvement over the partial inhibitor structure in the complex, which was previously determined at a nominal resolution of 2.6 Å by the multiple isomorphous replacement method. This study provides the first high-resolution picture of the complex between a Kunitz-type proteinase inhibitor with its cognate proteinase. Many of the external loops of STI show high B-factors, both in the free and the complexed states, except the reactive site loop whose B-factors are dramatically reduced upon complexation. The reactive site loop of STI adopts a canonical conformation similar to those in other substrate-like inhibitors. The P1 carbonyl group displays no out-of-plane displacement and thus retains a nominal trigonal planar geometry. Modeling studies on the complex between a homologous Kunitz-type trypsin inhibitor DE-3 from Erythrina caffra and the human tissue-type plasminogen activator reveal a new insight into the specific interactions which could play a crucial role in their binding.

AB - The Kunitz-type trypsin inhibitor from soybean (STI) consists of 181 amino acid residues with two disulfide bridges. Its crystal structures have been determined in complex with porcine pancreatic trypsin in two crystal forms (an orthorhombic form at 1.75 Å resolution and a tetragonal form at 1.9 Å) and in the free state at 2.3 Å resolution. They have been refined to crystallographic X-values of 18.9%, 21.6% and 19.8%, respectively. The three models of STI reported here represent a significant improvement over the partial inhibitor structure in the complex, which was previously determined at a nominal resolution of 2.6 Å by the multiple isomorphous replacement method. This study provides the first high-resolution picture of the complex between a Kunitz-type proteinase inhibitor with its cognate proteinase. Many of the external loops of STI show high B-factors, both in the free and the complexed states, except the reactive site loop whose B-factors are dramatically reduced upon complexation. The reactive site loop of STI adopts a canonical conformation similar to those in other substrate-like inhibitors. The P1 carbonyl group displays no out-of-plane displacement and thus retains a nominal trigonal planar geometry. Modeling studies on the complex between a homologous Kunitz-type trypsin inhibitor DE-3 from Erythrina caffra and the human tissue-type plasminogen activator reveal a new insight into the specific interactions which could play a crucial role in their binding.

KW - β-trefoil fold

KW - Crystal structure

KW - Inhibition of plasminogen activator

KW - Kunitz-type proteinase inhibitor

KW - Soybean trypsin inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0032536108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032536108&partnerID=8YFLogxK

U2 - 10.1006/jmbi.1997.1469

DO - 10.1006/jmbi.1997.1469

M3 - Article

VL - 275

SP - 347

EP - 363

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 2

ER -